Results 1 to 10 of about 100,970 (274)

SYNTAX score II predicts long-term mortality in patients with one- or two-vessel disease. [PDF]

PLoS ONE, 2018
OBJECTIVE:SYNTAX score II (SSII) is a long-term mortality prediction model to guide the decision making of the heart-team between coronary artery bypass grafting or percutaneous coronary intervention (PCI) in patients with left main or three-vessel ...
Maxime M Vroegindewey, Anne-Sophie Schuurman, Rohit M Oemrawsingh, Robert-Jan van Geuns, Isabella Kardys, Jurgen Ligthart, Joost Daemen, Eric Boersma, Patrick W Serruys, K Martijn Akkerhuis   +9 more
doaj   +14 more sources

Impacts of the SYNTAX score I, II and SYNTAX score II 2020 on left main revascularization [PDF]

Scientific Reports
Patients with left main coronary artery disease (LMCAD) with a high SYNTAX score (SS) were excluded from randomized studies that comparing percutaneous coronary intervention (PCI) and coronary artery bypass grafting (CABG).
Wei-Ting Sung, Ming-Ju Chuang, Yi-Lin Tsai, Ruey-Hsing Chou, Chun-Chin Chang, Po-Hsun Huang   +5 more
doaj   +4 more sources

Residual SYNTAX score II and complex percutaneous coronary interventions [PDF]

Journal of the Saudi Heart Association, 2018
Levent Cerit
doaj   +4 more sources

The association of the Syntax score II with carotid intima media thickness and epicardial fat tissue [PDF]

Indian Heart Journal, 2017
Aim: Syntax score II (SSII) is a highly predictive scoring system, which is used to improve individualized assessment of patients with complex coronary artery disease and facilitates clinical decision making.
Uğur Aksu, Oktay Gulcu, Zeynep Bilgi, Selim Topcu, Serdar Sevimli, Ednan Bayram, Ibrahim Halil Tanboğa   +6 more
doaj   +5 more sources

Functional (Re)Development of SYNTAX Score II 2020: Predictive Performance and Risk Assessment. [PDF]

J Clin Med, 2023
The present study investigates the prognostic value of the Syntax Score II 2020 corrected for flow-limiting lesions and its ability to better address treatment by benefit prediction among patients with left main or multivessel disease. We analyzed 1274 patients from the HALE-BOPP cohort and integrated the Syntax Score II 2020 with the result of the ...
Scala A, Erriquez A, Verardi FM, Marrone A, Scollo E, Trichilo M, Durante A, Tedeschi D, Cortese B, Ielasi A, Valentini G, Tebaldi M, Campo G, Pavasini R, Biscaglia S.   +14 more
europepmc   +4 more sources

External validation of SYNTAX score II in a real-world cohort undergoing coronary artery bypass grafting [PDF]

Journal of Cardiothoracic Surgery
Background Our aim was to evaluate SYNTAX Score II for its ability to predict mortality in all-comers undergoing isolated coronary artery bypass grafting.
Philipp Angleitner, Hannes Abfalterer, Alexandra Kaider, Emely Manville, Martin Bichler, Michael Graber, Leo Pölzl, Daniel Zimpfer, Sigrid Sandner, Nikolaos Bonaros   +9 more
doaj   +2 more sources

Prognostic values of SYNTAX score II in patients with coronary artery disease undergoing percutaneous coronary intervention – Cohort study [PDF]

Indian Heart Journal
Background: The data on prognostic values of SYNTAX score II in patients undergoing percutaneous coronary intervention is limited. We report predictive utility of SYNTAX score II in relation to in hospital and 1 year mortality of the patients undergoing ...
Santhosh Satheesh, Ritesh Kumar, Ajith Ananthakrishna Pillai, Raja Selvaraj, Sreekumaran Nair, Dhivya Priya   +5 more
doaj   +2 more sources

The Utility of the SYNTAX Score II and SYNTAX Score 2020 for Identifying Patients with Three-Vessel Disease Eligible for Percutaneous Coronary Intervention in the Multivessel TALENT Trial: A Prospective Pilot Experience. [PDF]

Rev Cardiovasc Med, 2022
Background: Personalized prognosis plays a vital role in deciding between percutaneous coronary intervention (PCI) and coronary artery bypass grafting (CABG) in patients with three-vessel disease (3VD). The aim of this study is to compare the modality of revascularization chosen by the local heart team to that recommended by using individualized ...
Ninomiya K, Serruys PW, Garg S, Hara H, Masuda S, Kageyama S, Kotoku N, Sevestre E, Kumar A, O'Kane P, Zaman A, Farah B, Magro M, Oemrawsingh RM, Möllmann H, Meneveau N, Achenbach S, Lemoine J, Allali A, Gallagher S, Wykrzykowska J, Lesiak M, Silvestri M, Wijns W, Sharif F, Onuma Y.   +25 more
europepmc   +6 more sources

Utilization of SYNTAX Score II for Predictive Clinical Outcomes in Patients with Coronary Artery Disease and Chronic Renal Insufficiency Following Percutaneous Coronary Intervention [PDF]

Reviews in Cardiovascular Medicine
Background: The SYNTAX score II (SS II) has earned widespread recognition for use on individuals with coronary artery disease (CAD) due to its reliable predictions of 4-year all-cause mortality (ACM).
Liqiu Yan, Dong Han, Yabin Wang, Sulei Li, Wei Yan, Nan Guo, Ying Mao, Qian Yang, Mengyao Li, Yumeng Lei, Shuaiyong Zhang, Feng Cao   +11 more
doaj   +2 more sources

Prognostic significance of residual functional SYNTAX score II in acute myocardial infarction. [PDF]

PLoS ONE
BackgroundThe residual functional SYNTAX (Synergy Between Percutaneous Coronary Intervention with Taxus and Cardiac Surgery) score (rFSS) predicts patient prognosis post-percutaneous coronary intervention (PCI).
Xinjun Lin, Zhendong Cheng, Wei Ji, Zhibin Mei, Yaoguo Wang, Chaoxiang Xu   +5 more
doaj   +2 more sources